Back to STATE STREET CORP STATE STREET CORP

ARCTARCT
Showing 8 of 11 quarters

Position history for STATE STREET CORPSTATE STREET CORP's holdings in ARCTURUS THERAPEUTICS HLDGS

STATE STREET CORP holds 569,598 shares of ARCT (ARCTURUS THERAPEUTICS HLDGS), worth $3.8M as of 2026-Q2. The position was increased (+4.7% shares). ARCT represents 0.0% of STATE STREET CORP's portfolio.

Current Value

$3.8M

Current Shares

569,598

Total Value Change

-$30.4M

Total Shares Change

-903,357

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
569,598
+4.7%
$3.8M0.0%$6.72
28
2026-Q1
Decreased
543,863
-3.6%
$4.2M0.0%$7.91
0
2025-Q4
Decreased
564,266
-46.0%
$3.5M0.0%$6.19
0
2025-Q3
Increased
1M
+2.5%
$19.3M0.0%$18.78
29
2025-Q2
Decreased
1M
-20.4%
$13.3M0.0%$13.33
0
2025-Q1
Decreased
1.3M
-3.5%
$13.6M0.0%$11.58
0
2024-Q4
Decreased
1.3M
-10.0%
$22.5M0.0%$16.58
0
2024-Q3
Decreased
1.5M
-3.3%
$34.2M0.0%$22.03
0

Other major holders of ARCT: BNP PARIBAS FINANCIAL MARKETS, ARK Investment Management LLC, FEDERATED HERMES, INC.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used